Consortium Acts To Revive Drug Development Projects For Brain Diseases Such As Alzheimer’s

Consortium Acts To Revive Drug Development Projects For Brain Diseases Such As Alzheimer’s
The Neurodegeneration Medicines Acceleration Program (Neuro-MAP) led by MRC Technology is a non-profit organization that brings together promising drug projects for brain diseases like Parkinson’s and Alzheimer’s that have stalled due to lack of support with funding organizations. Their goal is to revive these projects by helping scientists continue their research and develop potentially effective therapies. Currently, there are more than 50 million people

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *